Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison
NCT ID: NCT01002456
Last Updated: 2015-04-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
220 participants
INTERVENTIONAL
2009-10-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients.
NCT02149940
Impact of Beta-blockers on Physical Function in HFpEF
NCT04767061
Evaluation of Clinical and Genetic Modifiers of Long-term Survival in Heart Failure
NCT03461107
Community Pharmacy Medication Therapy Management for Heart Failure
NCT03608085
Heart Failure Medication Adherence
NCT03402750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Level 1: site-specific information
provide site-specific information on nonadherence
Level 1: (provide site-specifi information)
provide site-specific information on non-adherence to guideline
Level 2: site-, patient-specific info
provide site- and patient-specific information on nonadherence
Level 2 (Provide site- and patient-specific information)
provide site-specific information on non-adherence to guideline as well as list of patients with non-adherent prescriptions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Level 1: (provide site-specifi information)
provide site-specific information on non-adherence to guideline
Level 2 (Provide site- and patient-specific information)
provide site-specific information on non-adherence to guideline as well as list of patients with non-adherent prescriptions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males and females
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Madeline McCarren, PhD MPH
Role: PRINCIPAL_INVESTIGATOR
Edward Hines Jr. VA Hospital, Hines, IL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VMS #120
Identifier Type: OTHER
Identifier Source: secondary_id
RRP 09-136
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.